Journal of Clinical Epidemiology
Volume 57, Issue 12 , Pages 1253-1261 , December 2004

Likelihood ratio and a Bayesian approach were superior to standard noninferiority analysis when the noninferiority margin varied with the control event rate

,Accepted 28 May 2004.

References 

  1. Rohmel J. Therapeutic equivalence investigations: statistical considerations. Stat Med. 1998;17:1703–1714
  2. Wiens BL. Choosing an equivalence limit for noninferiority or equivalence studies. [Erratum in: Control Clin Trials 2002;23:774.] Control Clin Trials. 2002;23:2–14
  3. Blackwelder WC. “Proving the null hypothesis” in clinical trials. Control Clin Trials. 1982;3:345–353
  4. Garbe E, Rohmel J, Gundert-Remy U. Clinical and statistical issues in therapeutic equivalence trials. Eur J Clin Pharmacol. 1993;45:1–7
  5. Jones B, Jarvis P, Lewis JA, Ebbutt AF. Trials to assess equivalence: the importance of rigorous methods. [Erratum in: BMJ 1996;313: 550.] BMJ. 1996;313:36–39
  6. Rodary C, Com-Nougue C, Tournade M. How to establish equivalence between treatments: a one-sided clinical trial in paediatric oncology. Stat Med. 1989;8:593–598
  7. Siegel J. Equivalence and noninferiority trials. Am Heart J. 2000;139:S166–S170
  8. Hauck W, Anderson S. Some issues in the design and analysis of equivalence trials. Drug Inf J. 1999;33:109–118
  9. D'Agostino RB, Massaro JM, Sullivan LM. Non-inferiority trials: design concepts and issues—the encounters of academic consultants in statistics. Stat Med. 2003;22:169–186
  10. U.S. Food and Drug Administration, Division of Anti-infective Drug Products, Clinical Development and Labeling of Anti-Infective Drug Products. Points-to-consider. Washington, DC: U.S. Food and Drug Administration; 1992;
  11. Bristol D. Determining equivalence and the impact of sample size in anti-infective studies: a point to consider. J Biopharm Stat. 1996;6:319–326
  12. Phillips KF. A new test of non-inferiority for anti-infective trials. Stat Med. 2003;22:201–212
  13. Hung HMJ, Wang SJ, Tsong Y, O'Neil RT. Some fundamental issues with noninferiority testing in active controlled trials. Stat Med. 2003;22:213–225
  14. Rohmel J, Mansmann U. Unconditional nonasymptotic one-sided tests for independent binomial proportions when the interest lies in showing noninferiority and/or superiority. Biom J. 1999;41:149–170
  15. Farrington CP, Manning G. Test statistics and sample size formulae for comparative binomial trials with null hypothesis of non-zero risk difference or non-unity relative risk. Stat Med. 1990;9:1447–1454
  16. Gelman A, Carlin JB, Stern HS, Rubin DB. Bayesian data analysis. 2nd ed.. London: Chapman & Hall; 2003;
  17. Grieve AP. Joint equivalence of means and variances of two populations. J Biopharm Stat. 1998;8:377–390
  18. Thall PF, Simon RM, Estey EH. Bayesian sequential monitoring designs for single-arm clinical trials with multiple outcomes. Stat Med. 1995;14:357–379
  19. Gould AL. Sample sizes for event rate equivalence trials using prior information. Stat Med. 1993;12:2009–2023
  20. Chernoff H. On the distribution of the likelihood ratio. Ann Math Stat. 1954;25:573–578
  21. Chan IS. Exact tests of equivalence and efficacy with a non-zero lower bound for comparative studies. Stat Med. 1998;17:1403–1413
  22. Berger RL, Boos DD. P-values maximized over a confidence set for the nuisance parameter. J Am Stat Assoc. 1994;89:1012–1016
  23. Racine-Poon A, Grieve AP, Fluhler H, Smith AF. A two-stage procedure for bioequivalence studies. Biometrics. 1987;43:847–856
  24. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, et al. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA. 2002;288:321–333
  25. Joseph L, du Berger R, Belisle P. Bayesian and mixed Bayesian/likelihood criteria for sample size determination. Stat Med. 1997;16:769–781

 Supported by National Institute of Health grant nos. UO1 AR42540-03 and P30 CA13330.

PII: S0895-4356(04)00168-4

doi: 10.1016/j.jclinepi.2004.05.005

Journal of Clinical Epidemiology
Volume 57, Issue 12 , Pages 1253-1261 , December 2004

Article Tools

* Image Usage & Resolution